Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 506.09M P/E - EPS this Y -39.70% Ern Qtrly Grth -
Income -112.11M Forward P/E -8.59 EPS next Y 0.60% 50D Avg Chg -5.00%
Sales 14.84M PEG 0.05 EPS past 5Y - 200D Avg Chg 15.00%
Dividend N/A Price/Book 6.20 EPS next 5Y -126.60% 52W High Chg -21.00%
Recommedations 1.50 Quick Ratio 5.63 Shares Outstanding 84.38M 52W Low Chg 93.00%
Insider Own 19.50% ROA -40.69% Shares Float 48.19M Beta 0.22
Inst Own 53.22% ROE -181.73% Shares Shorted/Prior 12.33M/12.49M Price 7.82
Gross Margin 69.52% Profit Margin - Avg. Volume 653,758 Target Price 24.00
Oper. Margin -743.29% Earnings Date Nov 5 Volume 339,815 Change 0.26%
About Liquidia Corporation

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company also offers Remodulin, a treprostinil administered through continuous intravenous and subcutaneous infusion. The company also a license agreement with Pharmosa Biopharm Inc to develop and commercialize L606, an inhaled sustained-release formulation of Treprostinil for the treatment of PAH and PH-ILD. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.

Liquidia Corporation News
12/18/24 December 2024 US Growth Stocks With Strong Insider Ownership
12/12/24 Here’s Arquitos Capital Management’s Updates on Liquidia (LQDA)
12/12/24 Does Liquidia Technologies (LQDA) Have the Potential to Rally 132.54% as Wall Street Analysts Expect?
09:55 AM Wall Street Analysts See a 126.13% Upside in Liquidia Technologies (LQDA): Can the Stock Really Move This High?
11/19/24 3 US Growth Stocks With At Least 10% Insider Ownership
11/15/24 Liquidia Third Quarter 2024 Earnings: Beats Expectations
11/14/24 Liquidia Corp (LQDA) Q3 2024 Earnings Call Highlights: Strategic Advances Amidst Regulatory ...
11/13/24 Liquidia Technologies, Inc. (LQDA) Reports Q3 Loss, Tops Revenue Estimates
11/13/24 Liquidia Corporation Reports Third Quarter 2024 Financial Results and Provides Corporate Update
11/12/24 Liquidia to Present at the Stifel 2024 Healthcare Conference
11/07/24 Arcellx (ACLX) Stock Jumps 6.7%: Will It Continue to Soar?
11/07/24 Investors in Liquidia (NASDAQ:LQDA) have seen stellar returns of 186% over the past five years
11/06/24 Liquidia Corporation to Report Third Quarter 2024 Financial Results on November 13, 2024
11/04/24 Liquidia Corporation to Report Third Quarter 2024 Financial Results on November 11, 2024
11/01/24 Will Y-mAbs Therapeutics, Inc. (YMAB) Report Negative Earnings Next Week? What You Should Know
10/29/24 Liquidia Technologies, Inc. (LQDA) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
10/17/24 3 US Growth Stocks With High Insider Ownership And Earnings Growth Up To 61%
10/09/24 Liquidia Corp (LQDA) Q2 2024 Earnings Call Highlights: Navigating Challenges and Opportunities ...
10/08/24 Liquidia Technologies (LQDA) Surges 11.2%: Is This an Indication of Further Gains?
10/07/24 Liquidia Shares Jump After US Supreme Court Rejects United Therapeutics' Appeal in Patent Dispute
LQDA Chatroom

User Image evetsoloccip Posted - 2 days ago

We Wish You a $MNKD Christmas We Wish You a $MNKD Christmas We Wish You a $MNKD Christmas & a $LQDA New Year.......

User Image FuriousGeorge42 Posted - 5 days ago

$LQDA mnkd trolls so worried they come here to cry. Tick tock little fellas $LQDA Liquidia reports Q3 EPS (30c), consensus (37c) Reports Q3 revenue $4.4M, consensus $4.19M. Cash and cash equivalents totaled $204.4M as of September 30, compared to $83.6M as of December 31, 2023. Roger Jeffs, Liquidia's CEO, said: "This quarter we achieved our goal of adding pulmonary hypertension associated with interstitial lung disease to the indication statement for YUTREPIA. While the FDA decision to grant three-year exclusivity to TYVASO DPI, which will expire on May 23, 2025, currently gates our launch, we will exhaust every effort to bring YUTREPIA to market sooner, as evidenced by our litigation against the FDA to contest what we believe to be the improper grant of exclusivity to TYVASO DPI.

User Image Preacherclint10 Posted - 6 days ago

$LQDA Junk stock! EBITDA -95.84M Net Income Avi to Common (ttm) -112.11M Diluted EPS (ttm) -1.62 Quarterly Earnings Growth (yoy) -- Complete pump n dump!

User Image ra_VEEN Posted - 1 week ago

$LQDA could go either way here, no idea tbh

User Image clan Posted - 1 week ago

$UTHR $XBI $LQDA The flight to quality/safety is going on over to $MNKD Mannkind Corp. 25n25

User Image LorraineFleming328 Posted - 1 week ago

$LQDA SARA by AITX brings the future of AI security to enterprises, enhancing workflows and access control in January 2025.

User Image FuriousGeorge42 Posted - 1 week ago

$LQDA yeah she is. So much potential. 6 more months and gloves are off. Good earnings, good cash in the bank- solid base for takeoff.

User Image Preacherclint10 Posted - 2 weeks ago

You? $LQDA 💥

User Image ra_VEEN Posted - 2 weeks ago

$LQDA wtf

User Image grampslol Posted - 2 weeks ago

Was bad $MNKD data leaked to $LQDA ? They're flying !

User Image Fueler Posted - 2 weeks ago

$LQDA https://hntrbrk.com/liquidia-trial/

User Image JMG2000 Posted - 2 weeks ago

$LQDA 😳

User Image grampslol Posted - 11/27/24

$MNKD Cruising for a bruising when $LQDA launches their superior pah dpi product? Asking for a friend

User Image Preacherclint10 Posted - 4 weeks ago

$LQDA liquid diarrhea scam! Look for a crash as shorts get on board!

User Image ra_VEEN Posted - 1 month ago

$LQDA do I sell and buy more into $PLTR or sell more $PLTR and buy more $LQDA

User Image CeeRob53 Posted - 1 month ago

$LQDA they keep saying it and here we are back over 11$ in November

User Image ra_VEEN Posted - 1 month ago

$LQDA slow bleed til May

User Image NVDAMillionaire Posted - 1 month ago

$LQDA Liquidia Corporation (LQDA): Navigating the Path to Commercialization with Promising Pipeline https://beyondspx.com/article/liquidia-corporation-lqda-navigating-the-path-to-commercialization-with-promising-pipeline

User Image clan Posted - 1 month ago

$LQDA Liquidati💩 still does not have an approved trademark for Yutrepi💩 #thievesandliars #fraudsters #moredilutioncoming $UTHR = TD (total domination)

User Image Outslickd Posted - 1 month ago

$LQDA constantly a magnet to the whole numbers.

User Image Preacherclint10 Posted - 1 month ago

$LQDA scam-a-deia

User Image basedman Posted - 1 month ago

$LQDA still holding strong. big dumb to sell at these levels. May 2025 ultimate catalyst but lets see what this new admin does to the FDA…perhaps a quicker move once these muzzle this scumbag organization.

User Image ra_VEEN Posted - 1 month ago

$LQDA slow bleed til May

User Image NEWBIGTECH Posted - 1 month ago

$CHGG $LQDA $HOOD $FEMY $LUCD

User Image grampslol Posted - 1 month ago

$UTHR sinking AH $LQDA leak ? $MNKD

User Image MayorofMNKD Posted - 1 month ago

$LQDA …down again??

User Image Thestocktraderhubzee Posted - 1 month ago

WATCHLIST NOV 14 2024. $LUCD Needham Reiterates Buy on Lucid Diagnostics, Maintains $2.5 Price Target $LQDA Needham Reiterates Buy on Liquidia, Maintains $19 Price Target $HOOD Deutsche Bank Maintains Buy on Robinhood Markets, Raises Price Target to $35 $CHGG Piper Sandler Maintains Underweight on Chegg, Lowers Price Target to $1.5 $FEMY Chardan Capital Maintains Buy on Femasys, Lowers Price Target to $8

User Image d_risk Posted - 1 month ago

$LQDA - Liquidia - 10Q - Updated Risk Factors Multiple lawsuits from United Therapeutics, dependency on third-party FDA compliance, and restrictive financing covenants pose significant risks, alongside heightened competition and financial uncertainties. #Risk @Liquidia_Corp https://d-risk.ai/LQDA/10-Q/2024-11-13

User Image evetsoloccip Posted - 1 month ago

$MNKD $LQDA had a nice ER

User Image DonCorleone77 Posted - 1 month ago

$LQDA Liquidia reports Q3 EPS (30c), consensus (37c) Reports Q3 revenue $4.4M, consensus $4.19M. Cash and cash equivalents totaled $204.4M as of September 30, compared to $83.6M as of December 31, 2023. Roger Jeffs, Liquidia's CEO, said: "This quarter we achieved our goal of adding pulmonary hypertension associated with interstitial lung disease to the indication statement for YUTREPIA. While the FDA decision to grant three-year exclusivity to TYVASO DPI, which will expire on May 23, 2025, currently gates our launch, we will exhaust every effort to bring YUTREPIA to market sooner, as evidenced by our litigation against the FDA to contest what we believe to be the improper grant of exclusivity to TYVASO DPI. In the interim, we will use this pre-launch period to further advance knowledge of the clinical profile of YUTREPIA in PH-ILD patients through our ASCENT study, where we hope to show YUTREPIA's clear advantages related to the tolerability, titratability and durability in this underserved patient population."

Analyst Ratings
HC Wainwright & Co. Buy Aug 23, 24
Needham Buy Aug 22, 24
BTIG Buy Aug 20, 24
B of A Securities Buy Aug 20, 24
HC Wainwright & Co. Buy Aug 20, 24
BTIG Buy Aug 19, 24
Raymond James Strong Buy Aug 19, 24
Needham Buy Aug 19, 24
Raymond James Outperform Aug 16, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Adair Jason Chief Business Offic.. Chief Business Officer Dec 18 Sell 7.7 77 593 54,932 12/20/23
JEFFS ROGER Chief Executive Offi.. Chief Executive Officer Dec 14 Buy 7.16 139,665 1,000,001 640,805 12/18/23
Manning Paul B Director Director Dec 14 Buy 7.16 279,330 2,000,003 279,330 12/18/23
Caligan Partners LP - - Dec 14 Buy 7.16 1,117,318 7,999,997 11,280,945 12/14/23
Lippe Robert A Chief Operations Off.. Chief Operations Officer Nov 30 Sell 7.28 497 3,618 193,788 12/05/23
Moomaw Scott Chief Commercial Off.. Chief Commercial Officer Nov 30 Sell 7.28 542 3,946 106,737 12/05/23
Adair Jason Chief Business Offic.. Chief Business Officer Nov 30 Sell 7.28 452 3,291 54,478 12/05/23
Adair Jason Chief Business Offic.. Chief Business Officer Sep 19 Sell 6.51 75 488 53,637 09/20/23
Lippe Robert A Chief Operations Off.. Chief Operations Officer Aug 31 Sell 6.88 505 3,474 192,567 09/05/23
Moomaw Scott Chief Commercial Off.. Chief Commercial Officer Aug 31 Sell 6.88 537 3,695 105,404 09/05/23
Adair Jason Chief Business Offic.. Chief Business Officer Aug 31 Sell 6.88 445 3,062 53,452 09/05/23
Moomaw Scott Chief Commercial Off.. Chief Commercial Officer May 31 Sell 8.08 651 5,260 102,268 06/02/23
Lippe Robert A Chief Operations Off.. Chief Operations Officer Feb 28 Sell 7.56 2,033 15,369 188,524 03/02/23
Moomaw Scott Chief Commercial Off.. Chief Commercial Officer Feb 28 Sell 7.56 2,171 16,413 100,984 03/02/23
Kaseta Michael Chief Financial Offi.. Chief Financial Officer Sep 13 Buy 5.99 8,000 47,920 37,877 09/14/22
JEFFS ROGER Chief Executive Offi.. Chief Executive Officer Sep 06 Buy 5.568 43,820 243,990 159,827 09/07/22
Caligan Partners LP - - Sep 06 Buy 5.62 250,000 1,405,000 10,643,627 09/07/22
Moomaw Scott SVP, Commercial SVP, Commercial Aug 31 Buy 4.9045 2,160 10,594 9,810 09/01/22
Lippe Robert A Chief Operations Off.. Chief Operations Officer Aug 31 Buy 4.9045 1,918 9,407 98,026 09/01/22
Kaseta Michael Chief Financial Offi.. Chief Financial Officer Aug 31 Buy 4.9045 1,927 9,451 29,877 09/01/22
JEFFS ROGER Chief Executive Offi.. Chief Executive Officer Aug 31 Buy 4.9045 993 4,870 116,007 09/01/22
Kaseta Michael Chief Financial Offi.. Chief Financial Officer May 31 Buy 4.01 18,700 74,987 27,950 06/01/22
Caligan Partners LP - - May 25 Buy 3.40 79,400 269,960 10,393,627 05/26/22
Lippe Robert A Chief Operations Off.. Chief Operations Officer May 24 Buy 3.3751 29,628 99,997 90,692 05/25/22
JEFFS ROGER Chief Executive Offi.. Chief Executive Officer May 24 Buy 3.529 28,000 98,812 46,595 05/25/22
Caligan Partners LP - - May 17 Buy 5.9 221,104 1,304,514 10,314,227 05/19/22
Caligan Partners LP - - Apr 18 Buy 5.10 1,764,705 8,999,996 10,093,123 04/18/22